- Home
- NEUP vs TRIB Comparison
NEUP vs TRIB Comparison
Compare NEUP & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEUP
- TRIB
- Stock Information
- Founded
- NEUP 1996
- TRIB 1992
- Country
- NEUP United States
- TRIB Ireland
- Employees
- NEUP N/A
- TRIB N/A
- Industry
- NEUP
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- NEUP
- TRIB Health Care
- Exchange
- NEUP Nasdaq
- TRIB Nasdaq
- Market Cap
- NEUP 9.3M
- TRIB 10.7M
- IPO Year
- NEUP N/A
- TRIB N/A
- Fundamental
- Price
- NEUP $4.74
- TRIB $0.84
- Analyst Decision
- NEUP Strong Buy
- TRIB
- Analyst Count
- NEUP 1
- TRIB 0
- Target Price
- NEUP $21.00
- TRIB N/A
- AVG Volume (30 Days)
- NEUP 10.9K
- TRIB 73.0K
- Earning Date
- NEUP 05-23-2025
- TRIB 05-27-2025
- Dividend Yield
- NEUP N/A
- TRIB N/A
- EPS Growth
- NEUP N/A
- TRIB N/A
- EPS
- NEUP N/A
- TRIB N/A
- Revenue
- NEUP $662,715.00
- TRIB $59,126,000.00
- Revenue This Year
- NEUP N/A
- TRIB $11.63
- Revenue Next Year
- NEUP N/A
- TRIB $10.13
- P/E Ratio
- NEUP N/A
- TRIB N/A
- Revenue Growth
- NEUP N/A
- TRIB N/A
- 52 Week Low
- NEUP $2.12
- TRIB $0.48
- 52 Week High
- NEUP $15.24
- TRIB $3.55
- Technical
- Relative Strength Index (RSI)
- NEUP N/A
- TRIB 64.93
- Support Level
- NEUP N/A
- TRIB $0.71
- Resistance Level
- NEUP N/A
- TRIB $0.84
- Average True Range (ATR)
- NEUP 0.00
- TRIB 0.06
- MACD
- NEUP 0.00
- TRIB 0.00
- Stochastic Oscillator
- NEUP 0.00
- TRIB 74.24
About NEUP Neuphoria Therapeutics Inc. Common Stock
Neuphoria Therapeutics Inc is a clinical stage biotechnology company dedicated to developing therapies that address the complex needs of individuals affected by neuropsychiatric disorders. The company is advancing its drug candidate, BNC 210, an oral, proprietary, selective negative allosteric modulator of the Alpha7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder and for chronic treatment of post-traumatic stress disorder.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.